Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
Lys Therapeutics has raised $5.9M in total funding. The most recent round was Grant. The last funding was announced in September 2025.
Lys Therapeutics's investors include Bpifrance, Michael J. Fox Foundation, Normandie Incubation, HTH, Pulsalys.
Lys Therapeutics is headquartered in Lyon, France.
Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
Lys Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lys Therapeutics — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/lys-therapeutics. Accessed November 12, 2026.
VCBacked. (2025). Lys Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/lys-therapeutics
{{cite web |title=Lys Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lys-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Lys Therapeutics? Request a listing update